Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,537,143
-
Share change
-
+9,132,298
-
Total reported value
-
$27,999,006
-
Price per share
-
$1.51
-
Number of holders
-
26
-
Value change
-
+$13,818,988
-
Number of buys
-
12
-
Number of sells
-
8
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q1 2019
As of 31 Mar 2019,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,537,143 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, INVESTOR AB, RENAISSANCE TECHNOLOGIES LLC, Vivo Capital, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Fosun International Ltd, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, and NEEDHAM INVESTMENT MANAGEMENT LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.